{"id":544263,"date":"2021-05-21T19:34:01","date_gmt":"2021-05-21T19:34:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=544263"},"modified":"2021-05-21T19:34:01","modified_gmt":"2021-05-21T19:34:01","slug":"peanut-allergy-pd-market-analysis-market-size-trends-epidemiology-leading-companies-and-therapies-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/peanut-allergy-pd-market-analysis-market-size-trends-epidemiology-leading-companies-and-therapies-delveinsight_544263.html","title":{"rendered":"Peanut Allergy (PD) Market Analysis, Market Size, Trends, Epidemiology, Leading Companies And Therapies | DelveInsight"},"content":{"rendered":"
\"Peanut<\/a><\/p>\n
\n
DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight\u2019s \u201cPeanut Allergy (PD) \u2013 Market Insights, Epidemiology, and Market Forecast-2030\u201d report delivers an in-depth understanding of the Peanut Allergy (PD), historical and forecasted epidemiology as well as the Peanut Allergy (PD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<\/div>\n

DelveInsight has launched a new report on “Peanut Allergy (PD) – Market Insights, Epidemiology, and Market Forecast-2030<\/strong>”.<\/p>\n

DelveInsight’s “Peanut Allergy (PD) – Market Insights, Epidemiology, and Market Forecast-2030<\/strong><\/a>” report delivers an in-depth understanding of the Peanut Allergy (PD), historical and forecasted epidemiology as well as the  Peanut Allergy (PD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

Some of the key facts of the Report:<\/strong><\/p>\n

    \n
  1. \n

    The prevalence has increased steadily over the past decade, mostly in the Western world. As per DelveInsight estimates, the total prevalent population of Peanut Allergy in the 7MM was found to be 8,640,527 in 2017. The estimates show higher prevalence in the US with 4,659,471 cases in 2017 and is a growing health problem in the US, specifically in children.<\/p>\n<\/li>\n

  2. \n

    Among the EU5 countries, France had the highest prevalent population of Peanut Allergy with 614,959 cases, followed by Germany and the United Kingdom.<\/p>\n<\/li>\n

  3. \n

    As per DelveInsight analysis, it is observed that Japan has the least number of prevalent cases (1,548,318 for 2017) of Peanut Allergy, among the 7MM.<\/p>\n<\/li>\n

  4. \n

    In terms of Gender-specific, most of the patients diagnosed with Peanut Allergy were male.<\/p>\n<\/li>\n

  5. \n

    The highest number of people affected with Peanut Allergy was found in the age group of 65 and above years.<\/p>\n<\/li>\n

  6. \n

    Based on the Severity, the diagnosed cases were divided into mild, moderate to severe. The total cases of mild and moderate to severe Peanut Allergy in the US varied as 2,341,384 and 1,153,219 respectively.<\/p>\n<\/li>\n<\/ol>\n

    Key benefits of the report:<\/strong><\/p>\n

    1. Peanut Allergy (PD) market report covers a descriptive overview and comprehensive insight of the Peanut Allergy (PD) epidemiology and Peanut Allergy (PD) market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)<\/p>\n

    2. The Peanut Allergy (PD) market report provides insights on the current and emerging therapies.<\/p>\n

    3. Peanut Allergy (PD) market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/p>\n

    4. The Peanut Allergy (PD) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Peanut Allergy (PD) market.<\/p>\n

    Request for sample pages: https:\/\/www.delveinsight.com\/sample-request\/peanut-allergy-market<\/span><\/a><\/strong><\/p>\n

    Peanut Allergy (PD): Overview<\/strong><\/p>\n

    An allergic response to peanuts usually occurs within minutes after exposure. Peanut allergy signs and symptoms can include: Skin reactions, such as hives, redness or swelling. Itching or tingling in or around the mouth and throat. Digestive problems, such as diarrhea, stomach cramps, nausea or vomiting.<\/p>\n

    The key players involved in the Peanut Allergy (PD) market<\/a>:<\/strong><\/p>\n

      \n
    1. \n

      DBV Technologies, <\/p>\n<\/li>\n

    2. \n

      AnaptysBio, <\/p>\n<\/li>\n

    3. \n

      Cam Allergy, <\/p>\n<\/li>\n

    4. \n

      HAL Allergy B.V<\/p>\n<\/li>\n<\/ol>\n

      The launch of the emerging therapies is expected to significantly impact the  Peanut Allergy (PD) treatment scenario in the upcoming years:-<\/strong><\/p>\n

      Drug covered<\/strong><\/p>\n

        \n
      1. \n

        Viaskin Peanut<\/p>\n<\/li>\n

      2. \n

        ANB020 <\/p>\n<\/li>\n

      3. \n

        CA002 <\/p>\n<\/li>\n

      4. \n

        HAL-MPE1 <\/p>\n<\/li>\n<\/ol>\n

        Request a free sample report @https:\/\/www.delveinsight.com\/sample-request\/peanut-allergy-market<\/span><\/a><\/strong><\/p>\n

        Table of Contents<\/strong><\/p>\n

        1. Report Introduction<\/p>\n

        2. Executive Summary<\/p>\n

        3. SWOT analysis<\/p>\n

        4. Peanut Allergy (PD) Patient Share (%) Overview at a Glance<\/p>\n

        5. Peanut Allergy (PD) Market Overview at a Glance<\/p>\n

        6. Peanut Allergy (PD) Disease Background and Overview<\/p>\n

        7. Peanut Allergy (PD) Epidemiology and Patient Population<\/p>\n

        8. Country-Specific Patient Population of Peanut Allergy (PD)<\/p>\n

        9. Peanut Allergy (PD) Current Treatment and Medical Practices<\/p>\n

        10. Unmet Needs<\/p>\n

        11. Peanut Allergy (PD) Emerging Therapies<\/p>\n

        12. Peanut Allergy (PD) Market Outlook<\/p>\n

        13. Country-Wise Peanut Allergy (PD) Market Analysis (2017–2030)<\/p>\n

        14. Market Access and Reimbursement of Therapies<\/p>\n

        15. Market drivers<\/p>\n

        16. Market barriers<\/p>\n

        17. Appendix<\/p>\n

        18. Peanut Allergy (PD) Report Methodology<\/p>\n

        19. DelveInsight Capabilities<\/p>\n

        20. Disclaimer<\/p>\n

        21. About DelveInsight<\/p>\n

        Related Reports:<\/strong><\/p>\n

        Peanut Allergy- Pipeline Insights, 2021<\/strong><\/p>\n

        “Peanut Allergy- Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Peanut Allergy market. A detailed picture of the Peanut Allergy pipeline landscape is provided, which includes the disease overview and Peanut Allergy treatment guidelines.<\/p>\n

        Peanut Allergy -Epidemiology Forecast to 2030<\/strong><\/p>\n

        DelveInsight’s ‘Peanut Allergy – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Peanut Allergy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/p>\n

        DelveInsight’s “Peanut Allergy (PD) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Peanut Allergy (PD), historical and forecasted epidemiology as well as the  Peanut Allergy (PD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

         <\/p>\n

        Media Contact<\/span>
        Company Name:<\/strong>         DelveInsight Business Research LLP<\/a>
        Contact Person:<\/strong> Kritika Rehani
        Email:<\/strong>         Send Email<\/a>
        Phone:<\/strong> 9193216187
        Address:<\/strong>304 S. Jones Blvd #2432
        City:<\/strong> Las Vegas
        State:<\/strong> Nevada
        Country:<\/strong> United States
        Website:<\/strong>         https:\/\/www.delveinsight.com\/<\/a><\/p>\n

        <\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

        DelveInsight Business Research LLP DelveInsight\u2019s \u201cPeanut Allergy (PD) \u2013 Market Insights, Epidemiology, and Market Forecast-2030\u201d report delivers an in-depth understanding of the Peanut Allergy (PD), historical and forecasted epidemiology as well as the Peanut Allergy (PD) market trends in the … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-544263","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/544263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=544263"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/544263\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=544263"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=544263"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=544263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}